NDA - Active ingredient - Document - PDFSEARCH.IO

First Page		Document Content
Aging-associated diseases Beta blockers Cardiomyopathy Alcohols Heart diseases Carvedilol Heart failure Dilated cardiomyopathy Myocardial infarction Medicine Health Cardiology		NDA #20297 Supplement amendment: 022 dated September 1, 2006 Sponsor: GlaxoSmithKline Name of Finished Product: Coreg® Name of Active Ingredient: carvedilol Proposed indication: pediatric patients with symptomatic syste Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 259,01 KB Share Document on Facebook

	conferenceseries.com International Conference on Global Summit on Heart Diseases October 20-21, 2016 Chicago, USA DocID: 1uSRo - View Document
	Did you know? You’ll find ocean ingredients flowing out of your medicine cabinet in everything from medicines that help fight cancer, arthritis, Alzheimer’s, heart disease, viruses and other diseases. DocID: 1udW0 - View Document
	IMPACT OF HEART DISEASE1 Cardiovascular or heart disease is a broad term for a range of diseases affecting the heart and blood vessels. Women account for half of the 16.5 million cardiovascular deaths that occur globall DocID: 1s5gK - View Document
	risk-review-physician-approval-form DocID: 1rqab - View Document
	My Blood Pressure Wallet Card DocID: 1rmCL - View Document